Codes / ICD10CM / I70.749

I70.749 Atherosclerosis of other type of bypass graft(s) of the left leg with ulceration of unspecified site

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Common Name: Left Leg Bypass Graft Atherosclerosis with Unspecified Ulceration
  • Medical Term: Atherosclerosis of other type of bypass graft(s) of the left leg with ulceration of unspecified site
  • ICD-10 Code: I70.749

Summary

Atherosclerosis of other type of bypass graft(s) of the left leg with ulceration of unspecified site refers to plaque buildup in bypass grafts used to restore blood flow to the left leg, accompanied by ulceration at an unspecified location. This condition narrows the graft, reducing blood flow and potentially leading to complications like graft failure or limb ischemia.

Causes

Atherosclerosis in bypass grafts develops due to the accumulation of fatty deposits, cholesterol, and other substances within the graft walls. This process is often accelerated by factors like poor blood flow, graft material, or underlying vascular disease, leading to narrowing and reduced graft function over time.

Risk Factors

  • Age (more common in older adults)
  • History of atherosclerosis or vascular disease
  • Smoking or tobacco use
  • Diabetes
  • Hypertension (high blood pressure)
  • High cholesterol or triglyceride levels
  • Sedentary lifestyle
  • Obesity

Symptoms

  • Leg pain during activity (claudication)
  • Reduced pulse or blood flow in the left leg
  • Skin changes (pale, cool, or shiny skin)
  • Non-healing wounds or ulcers on the left leg (site unspecified)
  • Numbness or weakness in the left leg
  • Graft-related complications (e.g., blockage or failure)

Diagnosis

Diagnosis involves a combination of clinical evaluation, imaging studies (e.g., Doppler ultrasound, angiography), and assessment of ulceration. Healthcare providers may also review medical history and perform physical exams to confirm the presence of atherosclerosis in the bypass graft and associated ulceration.

Treatment Options

Treatment focuses on managing atherosclerosis, promoting ulcer healing, and preserving graft function. Options may include medications (e.g., antiplatelet agents, statins), wound care, revascularization procedures, or graft revision. Lifestyle modifications and risk factor management are also key components.

Prognosis and Follow-Up

Prognosis depends on the severity of graft narrowing, ulceration, and overall vascular health. Regular follow-up is essential to monitor graft patency, ulcer healing, and address any complications. Long-term management of risk factors is critical to prevent disease progression.

Complications

  • Graft failure or occlusion
  • Limb ischemia or tissue loss
  • Infection of the ulcer
  • Chronic pain or disability
  • Increased risk of amputation

Lifestyle & Prevention

  • Quit smoking or avoid tobacco use
  • Maintain a balanced diet low in saturated fats
  • Engage in regular physical activity
  • Manage diabetes, hypertension, and cholesterol levels
  • Follow prescribed medications and treatment plans
  • Monitor and care for any wounds or ulcers promptly

When to Seek Professional Help

Seek medical attention if you experience worsening leg pain, non-healing ulcers, changes in skin color or temperature, or signs of infection (e.g., redness, swelling, fever). Prompt evaluation is important to prevent serious complications.

Tips for Medical Coders

Document the presence of atherosclerosis in the bypass graft, ulceration, and the unspecified site location. Ensure clinical documentation supports the use of I70.749, as specificity for the ulcer site is not required. Verify that the code aligns with the patient’s diagnosis and treatment.

Book a walkthrough

I70.749 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.